Results 151 to 160 of about 245,752 (174)
Some of the next articles are maybe not open access.
The Lancet, 2016
Atopic dermatitis (also known as atopic eczema) is a chronic inflammatory skin disease that is characterised by intense itching and recurrent eczematous lesions. Although it most often starts in infancy and affects two of ten children, it is also highly prevalent in adults.
Stephan, Weidinger, Natalija, Novak
openaire +2 more sources
Atopic dermatitis (also known as atopic eczema) is a chronic inflammatory skin disease that is characterised by intense itching and recurrent eczematous lesions. Although it most often starts in infancy and affects two of ten children, it is also highly prevalent in adults.
Stephan, Weidinger, Natalija, Novak
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2023
Atopic dermatitis (AD) is a common, chronic relapsing, and remitting inflammatory skin disease that is characterized by erythematous, scaly, and pruritic lesions often located over the flexural surfaces. Treatment goals of AD include the reduction of itching and burning, as well as the reduction of skin changes.
Karl T, Clebak +4 more
openaire +3 more sources
Atopic dermatitis (AD) is a common, chronic relapsing, and remitting inflammatory skin disease that is characterized by erythematous, scaly, and pruritic lesions often located over the flexural surfaces. Treatment goals of AD include the reduction of itching and burning, as well as the reduction of skin changes.
Karl T, Clebak +4 more
openaire +3 more sources
Current Opinion in Pediatrics, 1998
Atopic dermatitis is the most common skin disease of childhood, and its prevalence has steadily increased over the last three decades. A chronic, relapsing condition, atopic dermatitis has a significant impact on affected children, their families, and the community at large. Although the fundamental pathogenesis has remained elusive, intensive research
H J, Kim, P J, Honig
+7 more sources
Atopic dermatitis is the most common skin disease of childhood, and its prevalence has steadily increased over the last three decades. A chronic, relapsing condition, atopic dermatitis has a significant impact on affected children, their families, and the community at large. Although the fundamental pathogenesis has remained elusive, intensive research
H J, Kim, P J, Honig
+7 more sources
Journal of the American Academy of Dermatology, 1981
Atopic dermatitis is a chronically relapsing inflammatory skin disease with altered immune and pharmacologic responses. Elevated serum IgE probably reflects defective immune regulation. Various other cellular immune defects rise and fall exacerbations and remissions of skin inflammation.
openaire +4 more sources
Atopic dermatitis is a chronically relapsing inflammatory skin disease with altered immune and pharmacologic responses. Elevated serum IgE probably reflects defective immune regulation. Various other cellular immune defects rise and fall exacerbations and remissions of skin inflammation.
openaire +4 more sources
Allergy and Asthma Proceedings, 2019
Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory dermatosis characterized by pruritus, xerosis, and a close association with IgE mediated sensitization to aeroallergens and foods. More than 60% of children with AD are at risk to develop allergic rhinitis or asthma (the atopic march).
Neill, Peters, Anju T, Peters
openaire +2 more sources
Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory dermatosis characterized by pruritus, xerosis, and a close association with IgE mediated sensitization to aeroallergens and foods. More than 60% of children with AD are at risk to develop allergic rhinitis or asthma (the atopic march).
Neill, Peters, Anju T, Peters
openaire +2 more sources
British Journal of Dermatology, 2020
Baricitinib, an oral selective Janus kinase 1 and 2 inhibitor, effectively reduced atopic dermatitis (AD) severity in a phase II study with concomitant topical corticosteroids.
E. Simpson +23 more
semanticscholar +1 more source
Baricitinib, an oral selective Janus kinase 1 and 2 inhibitor, effectively reduced atopic dermatitis (AD) severity in a phase II study with concomitant topical corticosteroids.
E. Simpson +23 more
semanticscholar +1 more source
Current Opinion in Immunology, 1988
The article considers the pathogenesis, clinical signs, diagnosis, and treatment of atopic dermatitis.
openaire +4 more sources
The article considers the pathogenesis, clinical signs, diagnosis, and treatment of atopic dermatitis.
openaire +4 more sources
Advances in Pediatrics, 2007
Atopic dermatitis is an especially common and frustrating condition, and the prevalence is increasing. The disease can adversely affect the quality of life of patients and caregivers. Significant advances in our understanding of the pathogenesis have led to improvements in therapy.
Alexander K C, Leung +2 more
openaire +2 more sources
Atopic dermatitis is an especially common and frustrating condition, and the prevalence is increasing. The disease can adversely affect the quality of life of patients and caregivers. Significant advances in our understanding of the pathogenesis have led to improvements in therapy.
Alexander K C, Leung +2 more
openaire +2 more sources
Update on the Pathogenesis and Therapy of Atopic Dermatitis
Clinical reviews in allergy and immunology, 2021Hua-guo Li +4 more
semanticscholar +1 more source